The fundamentals of cardiovascular calcification: from cells to therapy
This project aims to uncover mechanisms of cardiovascular calcification using zebrafish to identify new therapeutic targets for improved treatment options.
Projectdetails
Introduction
With this project, I propose to identify fundamental mechanisms of cardiovascular calcification (CVC) and new therapeutic targets using zebrafish as a model system. CVC, characterized by progressive calcification of the soft tissue causing impaired blood circulation, is a frequent form of cardiovascular disease.
Background
Because the pathophysiology of CVC is highly heterogeneous, the exact cell types and signaling pathways triggering tissue calcification are still unknown, thus limiting therapy options. Most studies on CVC rely on in vitro systems, which fail to reproduce the multicellular environment, or mammalian in vivo models, which are limited for live imaging and high-throughput analyses.
Research Proposal
By combining my expertise in cardiovascular research and bone biology, I propose to use zebrafish as a model to elucidate the multifactorial mechanisms of CVC, focusing on different developmental stages and cardiovascular tissues.
Aim 1
- I will use a broad array of zebrafish genetic models to characterize the cellular dynamics, molecular mechanisms, and functional impact of CVC in vivo.
- I will also study the role of specific cell populations present in regenerating valves and human valve implants with CVC.
Aim 2
- I propose to identify new local and systemic therapeutic strategies to block/reverse CVC, taking advantage of the zebrafish's amenability for genetic manipulation and high-throughput screening.
- I will recruit bone-degrading cells to the CVC site and determine their potential to reverse tissue calcification.
- Moreover, I will select a short list of small molecules identified in a large-scale screen in zebrafish and will test their therapeutic potential in cardiovascular cells derived from hiPSCs of CVC patients.
Conclusion
Altogether, with this interdisciplinary approach, I expect to bring a new perspective on the mechanisms and therapeutic targets to block/reverse CVC, which could have a considerable impact on the European population, severely affected by these diseases.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.209.375 |
Totale projectbegroting | € 1.209.375 |
Tijdlijn
Startdatum | 1-10-2022 |
Einddatum | 30-9-2027 |
Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALEpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Real-time Multiscale Imaging of Pathological Calcification - Zooming in on Aortic Valve CalcificationDeveloping a designer tissue imaging platform to dynamically study extracellular matrix changes in Calcifying Aortic Valve Disease, aiming to uncover mechanisms for future drug therapies. | ERC Advanced... | € 2.500.000 | 2025 | Details |
Advanced human models of the heart to understand cardiovascular diseaseHeart2Beat aims to develop innovative 3D human cardiac models using microfluidic technology to enhance understanding and treatment of cardiovascular diseases through personalized medicine. | ERC Advanced... | € 2.500.000 | 2023 | Details |
Decoding Extracellular Vesicle-mediated organ crosstalk in vivoThis project aims to investigate hepatic extracellular vesicle-mediated inter-organ communication in vivo using a transparent zebrafish model to enhance understanding of their role in health and disease. | ERC Starting... | € 1.500.000 | 2023 | Details |
Development of novel 3D vascularized cardiac models to investigate Coronary Microvascular DiseaseThe 3DVasCMD project aims to develop a 3D vascularized cardiac model using iPSC technology to study coronary microvascular disease and identify therapeutic targets for improved cardiovascular health. | ERC Starting... | € 1.496.395 | 2022 | Details |
Mechanisms and consequences of cell state transitions during heart regenerationThis project aims to uncover the coordinated cellular responses in zebrafish heart regeneration post-injury using single-cell genomics and computational methods to enhance understanding of organ repair mechanisms. | ERC Consolid... | € 2.000.000 | 2023 | Details |
Real-time Multiscale Imaging of Pathological Calcification - Zooming in on Aortic Valve Calcification
Developing a designer tissue imaging platform to dynamically study extracellular matrix changes in Calcifying Aortic Valve Disease, aiming to uncover mechanisms for future drug therapies.
Advanced human models of the heart to understand cardiovascular disease
Heart2Beat aims to develop innovative 3D human cardiac models using microfluidic technology to enhance understanding and treatment of cardiovascular diseases through personalized medicine.
Decoding Extracellular Vesicle-mediated organ crosstalk in vivo
This project aims to investigate hepatic extracellular vesicle-mediated inter-organ communication in vivo using a transparent zebrafish model to enhance understanding of their role in health and disease.
Development of novel 3D vascularized cardiac models to investigate Coronary Microvascular Disease
The 3DVasCMD project aims to develop a 3D vascularized cardiac model using iPSC technology to study coronary microvascular disease and identify therapeutic targets for improved cardiovascular health.
Mechanisms and consequences of cell state transitions during heart regeneration
This project aims to uncover the coordinated cellular responses in zebrafish heart regeneration post-injury using single-cell genomics and computational methods to enhance understanding of organ repair mechanisms.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Engineering a living human Mini-heart and a swimming Bio-robotThe project aims to develop advanced in vitro human cardiac models, including a vascularized mini-heart and a bio-robot, to better assess cardiotoxicity and improve understanding of cardiovascular disease. | EIC Pathfinder | € 4.475.946 | 2022 | Details |
Bringing 3D cardiac tissues to high throughput for drug discovery screensDeveloping a high-throughput 3D cardiac model using microfluidic technology to enhance drug discovery for cardiovascular disease by improving predictive accuracy and scalability. | EIC Transition | € 1.457.500 | 2023 | Details |
Comprehensive Analysis of RBM20-induced Dilated Cardiomyopathies using Omics Approaches and Repair InterventionsCARDIOREPAIR aims to identify and therapeutically target RBM20 mutations in dilated cardiomyopathy using high-throughput genomics and bioengineering to improve heart health outcomes. | EIC Pathfinder | € 4.349.410 | 2023 | Details |
Engineering a living human Mini-heart and a swimming Bio-robot
The project aims to develop advanced in vitro human cardiac models, including a vascularized mini-heart and a bio-robot, to better assess cardiotoxicity and improve understanding of cardiovascular disease.
Bringing 3D cardiac tissues to high throughput for drug discovery screens
Developing a high-throughput 3D cardiac model using microfluidic technology to enhance drug discovery for cardiovascular disease by improving predictive accuracy and scalability.
Comprehensive Analysis of RBM20-induced Dilated Cardiomyopathies using Omics Approaches and Repair Interventions
CARDIOREPAIR aims to identify and therapeutically target RBM20 mutations in dilated cardiomyopathy using high-throughput genomics and bioengineering to improve heart health outcomes.